Clik here to view.
TÜV Rheinland Launches Eyesafe Display Standard, New Requirements Guide...
SHANGHAI The international independent third-party testing, inspection, and certification organization, TÜV Rheinland Group, has announced the launch of the Eyesafe Display Standard. It is based on...
View ArticleClik here to view.
TÜV Rheinland Launches Eyesafe Display Standard, New Requirements Guide...
SHANGHAI The international independent third-party testing, inspection, and certification organization, TÜV Rheinland Group, has announced the launch of the Eyesafe Display Standard. It is based on...
View ArticleClik here to view.
医療法人先進会 先進会眼科が、旧神戸神奈川アイクリニックの保証患者様向けに「神戸神奈川サポートプログラム」を開始
東京 （ビジネスワイヤ） — 医療法人先進会運営の先進会眼科は、東京、大阪など全国各地に屈折矯正専門では国内最大級の眼科クリニックが8月末に閉院し、運営母体の医療法人稜保会が2月5日に東京地方裁判所から破産開始決定を受け、かつ債権請求期限の3月4日を経過したことを受け、患者様保護および医療継続性の観点から「神戸神奈川サポートプログラム」を開始しました。...
View ArticleClik here to view.
Senshinkai Eye Clinics Started “Kobe Kanagawa Support Program” for the...
TOKYO Senshinkai Eye Clinics, operated by Senshinkai Eye Institute, Inc., started the support program for the patients of Kobe Kanagawa Eye Clinic located in Tokyo and Osaka, formerly one of the...
View ArticleClik here to view.
RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related...
TOKYO RIBOMIC Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics (“RIBOMIC” TSE-Mothers : 4591, President and CEO : Yoshikazu Nakamura, Ph.D.) today announced that...
View ArticleClik here to view.
Notice Regarding Business Alliance Between Sanbio and Ocumension in the...
TOKYO SanBio Co., Ltd. (Keita Mori, Representative Director and President, hereinafter “SanBio”) (TOKYO:4592) hereby announces that SanBio has entered into a business alliance with Ocumension (Hong...
View ArticleClik here to view.
Smart Eye Camera Got Listed in the Valued Supplier List of IAPB for the First...
TOKYO OUI Inc., announced today that our medical device Smart Eye Camera (SEC), a smartphone attachment which functions as a conventional slit-lamp microscope and able to record the ophthalmological...
View ArticleClik here to view.
Topcon Singapore Medical Announces its New Managing Director
SINGAPORE Topcon Singapore Medical Pte. Ltd. (“TSM”) has announced that Leo Hiroshi Nagatake, who is currently leading Topcon Healthcare Solutions Asia Pacific (”THSAP”), has been appointed as TSM’s...
View ArticleClik here to view.
Arctic Vision Announces Formation of Scientific Advisory Board
SHANGHAI Arctic Vision, a clinical stage biotechnology company focusing on the development and commercialization of innovative ophthalmology therapies in China and Asia, announced today the...
View ArticleClik here to view.
Samsung Bioepis Announces 24-week Interim Results from a Phase 3 Trial of...
INCHEON, Korea Samsung Bioepis Co., Ltd. announced today that the primary endpoints have been met in the randomized, double-masked, phase 3 trial comparing the efficacy, safety and immunogenicity of...
View ArticleClik here to view.
Harbour BioMed Receives Chinese Regulatory Approval of IND Application to...
CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SUZHOU, China Harbour BioMed (HBM) today announced that National Medical Products Administration (NMPA, China) approved its IND application...
View ArticleClik here to view.
ソウル半導体、健康と学習をサポートする太陽光スペクトルLED “SunLike”をシーリングライト向けに供給
韓国安山市 （ビジネスワイヤ） — 世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd....
View ArticleClik here to view.
Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Adopted by...
ANSAN, South Korea Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global compound semiconductor, announced that its SunLike Series natural spectrum LEDs have been adopted by KOIZUMI...
View ArticleClik here to view.
Eyenuk宣布FDA核准EyeArt自主AI系统用于糖尿病视网膜病变筛查
洛杉矶 (美国商业资讯)–Eyenuk, Inc.是一家全球性人工智能(AI)医疗技术和服务公司，是AI眼病筛查真实世界应用的领导者，公司今天宣布，美国食品药品管理局(FDA)已签发该公司用于糖尿病视网膜病变的EyeArt®自主AI系统上市的510(k)核准(K200667)，该病变是美国成人失明的主要病因。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Eyenuk、糖尿病網膜症スクリーニング用のEyeArt自律的AIシステムに対するFDA認可の取得を発表
ロサンゼルス （ビジネスワイヤ） — 人工知能（AI）医療技術・サービスの世界的企業で、AIアイ・スクリーニング向け実臨床アプリケーションのリーダー企業のEyenuk, Inc.は本日、米国の成人における失明の主因となっている糖尿病網膜症に対する自律的AIシステムEyeArt®の上市につき、米国食品医薬品局（FDA）より510(k)認可（K200667）を取得したと発表しました。...
View ArticleClik here to view.
Chugai’s Enspryng (Satralizumab) Receives Regulatory Approval from FDA for...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that the U.S. Food and Drug Administration (FDA) has approved the pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody,...
View ArticleClik here to view.
Kubota Vision Completes POC Clinical Study Using Wearable Myopia Control...
SEATTLE Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the...
View ArticleClik here to view.
New Data of Chugai’s Enspryng (Satralizumab) on Risk and Severity of Relapse...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced the presentation of new Enspryng® (generic name: satralizumab [genetical recombination]) data on reducing relapse severity in the...
View ArticleClik here to view.
Desk Lamps With Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs...
ANSAN, South Korea Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global compound semiconductor, announced that desk lamps with its SunLike Series natural spectrum LEDs, which help improve...
View ArticleClik here to view.
KILL Desk Lamps With Seoul Semiconductor’s SunLike Series Natural Spectrum...
Seoul Semiconductor requests that their press release NewsItemId: 20200910006083 issued September 11, 2020 “Desk Lamps With Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Sold at Costco,...
View Article